Allendale, NJ (USA) and Basel, Switzerland, 21 November 2014 – Lonza Inc. has appointed Azelis Americas (KDG) as their representative for the Functional Chemicals line of products from 1 December 2014. The functional ingredients are typically sold into the plastic additives and construction markets under the brand names of Acrawax™, Glycolubes™, Glycosperse™ and Lonzest™.
KDG CASE and KDG Industrial verticals bring exceptional expertise in the Coatings, Adhesives, Sealants & Elastomers CASE and plastics market with their unique technical centers, application knowledge, strong marketing expertise and technical sales professionals. KDG Industrial (Monson) and KDG CASE (Ribelin, EW Kaufmann, GMZ and PT Hutchins) will be adding these products to their current Lonza portfolio of products.
Since 2010, KDG CASE has been representing the Lonza Industrial Solutions “Biocides” line of products: Omadine™, Proxel™, Reputain™, Densil™ and Omacide™. “KDG has done an excellent job growing our business; we look forward to working together further with our Functional Ingredients products,” said Julie Gallucci, Lonza’s Head of NAFTA Industrial Solutions.
Frank Bergonzi, CEO and President of Azelis Americas, said, “This new specialty portfolio further strengthens our business relationship with our strategic partner, Lonza. It complements our industry verticals and adds to the breadth of our product portfolio by offering technologies from world-class suppliers, while enabling KDG to provide industry-leading technical sales, support and application expertise.”
About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.
Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 10,000 employees worldwide. The company generated sales of about CHF 3.6 billion in 2013 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Lonza’s stock is publicly traded on the Swiss and the Singapore stock exchanges. Further information can be found at www.lonza.com
